National implementation of a race-neutral eGFR equation contributed to more modifications and higher kidney transplantation rates for Black candidates, according to study data published in the Journal ...
Empagliflozin therapy was associated with improved kidney outcomes regardless of diabetes, HF, cause of kidney disease, or severity of kidney disease.
OmniAb, Inc. (NASDAQ: OABI) today reported financial results for the three and nine months ended September 30, 2025, and provided operating and partner program updates.
Urinary albumin-creatinine ratio (UACR) may be slightly better than urinary protein-creatinine ratio (UPCR) at predicting kidney failure-related clinical outcomes in chronic kidney disease (CKD), a ...
Editorial Note: We earn a commission from partner links on Forbes Advisor. Commissions do not affect our editors' opinions or evaluations. Disclaimer: Calculator results and default inputs are ...
Initial results of a Phase 1 / 2 open label study of AT-02, the company’s lead pan-amyloid removal therapeutic candidate, in patients with AL amyloidosis will be presented at ASH.The presentation ...
Radiofrequency renal denervation was associated with significant blood pressure reduction among individuals with chronic kidney disease.